Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 100.
394. lappuse
... portion with distilled water to obtain a known concentration of 0.02 milligram of loracarbef activity per milliliter . ( ii ) Preparation of sample solutions . Di- lute an accurately measured portion of the sample with sufficient ...
... portion with distilled water to obtain a known concentration of 0.02 milligram of loracarbef activity per milliliter . ( ii ) Preparation of sample solutions . Di- lute an accurately measured portion of the sample with sufficient ...
409. lappuse
... portion of phosphoric acid solution and shake vig- orously . Centrifuge to obtain a clear separation of the two layers ( approxi- mately 20 seconds ) . If any penicillin procaine remains undissolved , add a third 0.5 - milliliter portion ...
... portion of phosphoric acid solution and shake vig- orously . Centrifuge to obtain a clear separation of the two layers ( approxi- mately 20 seconds ) . If any penicillin procaine remains undissolved , add a third 0.5 - milliliter portion ...
410. lappuse
... portion of the dis- solution medium as a sample - blank so- lution . Place one tablet into the bas- ket , and lower it into its proper posi- tion in the tank . Rotate the basket at 100 + 5 revolutions per minute in a clock- wise ...
... portion of the dis- solution medium as a sample - blank so- lution . Place one tablet into the bas- ket , and lower it into its proper posi- tion in the tank . Rotate the basket at 100 + 5 revolutions per minute in a clock- wise ...
422. lappuse
... portion of ap- proximately 50 milligrams of sample with distilled water to obtain a con- centration of 0.5 milligram per milli- liter ( estimated ) ; also , reconstitute the sample as directed in the labeling . Then using a suitable ...
... portion of ap- proximately 50 milligrams of sample with distilled water to obtain a con- centration of 0.5 milligram per milli- liter ( estimated ) ; also , reconstitute the sample as directed in the labeling . Then using a suitable ...
426. lappuse
... portion of the cephradine working standard into a suitably sized container . Add 5.0 milli- liters of distilled water and place in an ultrasonic bath to facilitate dissolu- tion . Dilute with a sufficient amount of mobile phase to ...
... portion of the cephradine working standard into a suitably sized container . Add 5.0 milli- liters of distilled water and place in an ultrasonic bath to facilitate dissolu- tion . Dilute with a sufficient amount of mobile phase to ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning